Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
This makes VLCC the sole institution in the country authorised to conduct in-person NCLC exams
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The move comes as drug developers face mounting pressure from faster timelines and increasingly complex manufacturing processes
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
It promises fewer injections for vision loss patients
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
The company, part of pharma powerhouse AbbVie, will showcase the findings—and the next evolution of its AA Signature framework—at AMWC 2026 in Monaco,
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
Subscribe To Our Newsletter & Stay Updated